Blog

Posted:

FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system. Read more here.

Read more
Posted:

European Commission approves Roche’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has granted marketing authorisation for Tecentriq® SC (atezolizumab), the European Union (EU)’s first PD-(L)1 cancer immunotherapy for subcutaneous (under the skin) injection. Read more here.

Read more
Posted:

Walking for wellness / Art & soul groups

Check out this fascinating share on walking for wellness / Art & soul groups.  Download and read the full project report.

Read more
Posted:

Virtual Medical Expert Training in Peripheral Bronchoscopy

The Virtual Medical Expert Training gives a comprehensive overview on diagnosis and treatment options for peripheral pulmonary nodules. The aim is to discuss pre-recorded cases and tips & tricks for a safe and effective procedure. Read more here.

Read more
Posted:

SEHTA registers with Innovate UK’s business growth service’s Catapults & RTOs Grant Scheme

Innovate UK EDGE, the innovation agency’s business growth service, is partnering with Catapults and RTOs across the UK to award 100% funded grants of up to £15,000 to suitable high-growth SMEs as part of their advisory support. Read more here.

Read more
Posted:
Posted:

ORCHA & Alpha MD join forces to transform digital health in India

ORCHA, the Organisation for the Review of Health and Care Apps, and Alpha MD, a leading player in healthcare innovation, are proud to announce a strategic partnership aimed at shaping and supporting digital health delivery in India. The collaboration will kick off…

Read more
Posted:

NIHR i4i & OLS Real World Evidence Programme briefing

The NIHR i4i Programme, in collaboration with the Office for Life Sciences (OLS) and the National Institute for Health and Care Excellence (NICE), invites applications to the NIHR i4i & OLS Real World Evidence Programme. An online launch event will…

Read more
Posted:

‘Brilliant’ remote monitoring tool potentially averts stroke for Care Home resident with learning disabilities

A learning disability home in Coventry and Warwickshire has recently reported back on its remote monitoring successes. Lisa Halliman, Manager of a Care Home in Radford, described the remote monitoring service as ‘brilliant’ and singled out the Docobo technology-enabled Monthly…

Read more
Posted:

Ozempic, Wegovy, other GLP-1RA drugs not linked to increased pancreatic cancer risk, study finds

New research has concluded that drugs from the glucagon-like peptide-1 receptor agonists (GLP-1RA) class do not increase the risk of pancreatic cancer. Read more here.

Read more
Posted:

New research reveals a brain-fat tissue feedback loop that influences aging

A new study reveals a vital brain-fat tissue feedback loop that plays a pivotal role in aging. The research identifies specific neurons in the hypothalamus that, when activated, signal the body’s fat tissue to release energy, facilitating physical activity and…

Read more
Posted:

atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics

atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced a strategic investment in Beckley Psytech Limited (“Beckley Psytech”), a private clinical-stage biotechnology company dedicated to transforming short-duration psychedelics…

Read more